- Home
- ASTS vs BBIO Comparison
ASTS vs BBIO Comparison
Compare ASTS & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTS
- BBIO
- Stock Information
- Founded
- ASTS 2019
- BBIO 2015
- Country
- ASTS United States
- BBIO United States
- Employees
- ASTS N/A
- BBIO N/A
- Industry
- ASTS Telecommunications Equipment
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ASTS Consumer Discretionary
- BBIO Health Care
- Exchange
- ASTS Nasdaq
- BBIO Nasdaq
- Market Cap
- ASTS 4.5B
- BBIO 5.1B
- IPO Year
- ASTS N/A
- BBIO 2019
- Fundamental
- Price
- ASTS $22.88
- BBIO $26.49
- Analyst Decision
- ASTS Strong Buy
- BBIO Strong Buy
- Analyst Count
- ASTS 4
- BBIO 13
- Target Price
- ASTS $43.68
- BBIO $47.92
- AVG Volume (30 Days)
- ASTS 7.5M
- BBIO 2.7M
- Earning Date
- ASTS 11-14-2024
- BBIO 11-12-2024
- Dividend Yield
- ASTS N/A
- BBIO N/A
- EPS Growth
- ASTS N/A
- BBIO N/A
- EPS
- ASTS N/A
- BBIO N/A
- Revenue
- ASTS $2,500,000.00
- BBIO $217,765,000.00
- Revenue This Year
- ASTS N/A
- BBIO $2,306.97
- Revenue Next Year
- ASTS $4,467.90
- BBIO N/A
- P/E Ratio
- ASTS N/A
- BBIO N/A
- Revenue Growth
- ASTS N/A
- BBIO 2209.77
- 52 Week Low
- ASTS $1.97
- BBIO $21.62
- 52 Week High
- ASTS $39.08
- BBIO $44.32
- Technical
- Relative Strength Index (RSI)
- ASTS 44.57
- BBIO 49.05
- Support Level
- ASTS $22.77
- BBIO $25.34
- Resistance Level
- ASTS $25.85
- BBIO $28.15
- Average True Range (ATR)
- ASTS 1.83
- BBIO 1.33
- MACD
- ASTS -0.05
- BBIO -0.24
- Stochastic Oscillator
- ASTS 16.11
- BBIO 24.73
About ASTS AST SpaceMobile Inc.
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers and finally bringing broadband to the billions who remain unconnected. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.